Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Regencell Bioscience Holdings Limited (RGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 4.77 million shares for the 12-month period ending 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-10-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|
| 2025-06-30 | 4.77M shares 20-F · filed 2025-10-31 | |
| 2024-06-30 | 1.73M shares 20-F · filed 2025-10-31 | 45.45K shares 20-F · filed 2024-10-25 |
| 2023-06-30 | 175.33K shares 20-F · filed 2024-10-25 | |
| 2022-06-30 | 275.33K shares 20-F · filed 2024-10-25 |